Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis
- PMID: 28814426
- DOI: 10.1136/annrheumdis-2017-211897
Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis
Keywords: ANCA-associated vasculitis; biologicals; eosinophilic granulomatosis with polyangiitis; rituximab.
Conflict of interest statement
Competing interests: None declared.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources